Mirae Asset Global ETFs Holdings
CRDF icon

Mirae Asset Global ETFs Holdings’s Cardiff Oncology CRDF Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-29,467
Closed -$47.7K – 3199
2026
Q1 		$47.7K Buy
29,467
+714
+2% +$1.47K ﹤0.01% 2915
2025
Q4 		$80.8K Sell
28,753
-38
-0.1% -$88 ﹤0.01% 2769
2025
Q3 		$59.3K Sell
28,791
-4,887
-15% -$13.5K ﹤0.01% 2903
2025
Q2 		$106K Sell
33,678
-641
-2% -$1.96K ﹤0.01% 2586
2025
Q1 		$108K Buy
34,319
+11,497
+50% +$45.5K ﹤0.01% 2598
2024
Q4 		$99K Buy
22,822
+988
+5% +$3.09K ﹤0.01% 2703
2024
Q3 		$58.3K Buy
+21,834
New +$51.6K ﹤0.01% 2891

Other funds holding CRDF

LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Mirae Asset Global ETFs Holdings's CRDF Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings sold out of Cardiff Oncology (CRDF) in Q2 2026, closing a stake of 29,467 shares — an estimated $47.7K sold.

Mirae Asset Global ETFs Holdings first reported a position in CRDF in Q3 2024 and held it in 7 quarters. The position peaked at $108K in Q1 2025. 105 funds tracked by Wall St. Rank hold CRDF as of Q2 2026.

  • Mirae Asset Global ETFs Holdings reported no remaining Cardiff Oncology position as of Q2 2026 after selling out during the quarter.
  • Mirae Asset Global ETFs Holdings sold 29,467 Cardiff Oncology shares in Q2 2026, an estimated $47.7K.
  • Mirae Asset Global ETFs Holdings first reported a position in Cardiff Oncology in Q3 2024 and held it in 7 quarters.
  • Mirae Asset Global ETFs Holdings's Cardiff Oncology position peaked at $108K in Q1 2025.
  • 105 funds tracked by Wall St. Rank held Cardiff Oncology as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.